Product Images Inmazeb
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Inmazeb NDC 61755-019 by Regeneron Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - inmazeb 01
PRINCIPAL DISPLAY PANEL - 14.5 mL Vial Carton - inmazeb 02
This is a description of a medication called Inmazeb. Each vial contains 241.7mg of atoltivimab, 241.7mg of maftivimab, and 241.7mg of odesivimab. The medication is to be administered intravenously after dilution. The solution shouldn't be frozen or shaken and must be stored at 2°C to 8°C (36°F to 46°F) in the original carton to protect it from light. Any unused portion of the solution should be discarded.*
inmazeb 03
This text describes a medication called Inmazeb that comes in a single-dose vial containing 483.3 mg of atoltivimab, maftivimab, and odesivimab. It should be injected intravenously after dilution as advised in the prescribing information. One can check the expiry date by scanning a QR code or visiting a specific website. The medication must be refrigerated and protected from light. The carton comes with a single-dose vial and prescribing information, and unused portions should be discarded. If the seal is broken or missing, do not use the vial.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
